Repatha

Cholesterol lowering drug approved by FDA

Aug 29, 2015 AM EDT The U.S Food and Drug Administration has granted approval to Repatha, (evolocumab), the second drug in a potent class, PCSK9 inhibitors, approved to treat high cholesterol.

Real Time Analytics